Thompson Craig B. has filed 16 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 1962 shares of REGENERON PHARMACEUTICALS, INC. ($REGN) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Thompson Craig B. | Director | A | Non-Qualified Stock Option (right to buy) | 1962 | $0.00 | 1,962.0000 | 137,600,000 | 9999.99% | 0.00% |
| Jan. 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Thompson Craig B. | Director | A | Common Stock | 155 | $0.00 | 775.0000 | 137,600,000 | 25.00% | 0.00% |
| May 21, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Thompson Craig B. | Director | A | Common Stock | 946 | $134.98 | 2,413.0000 | 51,201,000 | 64.49% | 0.00% |
| May 21, 2025 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Thompson Craig B. | Director | A | Stock Options (Right to Buy) | 2076 | $134.98 | 2,076.0000 | 51,201,000 | 9999.99% | 0.00% |
| Jan. 2, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | Thompson Craig B. | Director | A | Common Stock | 166 | $0.00 | 620.0000 | 136,000,000 | 36.56% | 0.00% |
| Jan. 2, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | Thompson Craig B. | Director | A | Non-Qualified Stock Option (right to buy) | 1958 | $0.00 | 1,958.0000 | 136,000,000 | 9999.99% | 0.00% |
| May 13, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Thompson Craig B. | Director | A | Common Stock | 559 | $228.41 | 1,467.0000 | 51,552,000 | 61.56% | 0.00% |
| May 13, 2024 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Thompson Craig B. | Director | A | Stock Options (Right to Buy) | 1311 | $228.41 | 1,311.0000 | 51,552,000 | 9999.99% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | Thompson Craig B. | Director | A | Non-Qualified Stock Option (right to buy) | 1607 | $0.00 | 1,607.0000 | 133,100,000 | 9999.99% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | Thompson Craig B. | Director | A | Common Stock | 135 | $0.00 | 454.0000 | 133,100,000 | 42.32% | 0.00% |
| May 15, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Thompson Craig B. | Director | A | Common Stock | 664 | $0.00 | 908.0000 | 50,944,000 | 272.13% | 0.00% |
| May 15, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Thompson Craig B. | Director | A | Stock Options (Right to Buy) | 1669 | $192.36 | 1,669.0000 | 50,944,000 | 9999.99% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | Thompson Craig B. | Director | A | Common Stock | 40 | $0.00 | 319.0000 | 130,400,000 | 14.34% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | Thompson Craig B. | Director | A | Non-Qualified Stock Option (right to buy) | 477 | $0.00 | 477.0000 | 130,400,000 | 9999.99% | 0.00% |
| Jan. 3, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Thompson Craig B. | Director | A | Stock Options (Right to Buy) | 592 | $218.40 | 592.0000 | 50,944,000 | 9999.99% | 0.00% |
| Jan. 3, 2023 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $CRL | Thompson Craig B. | Director | A | Common Stock | 244 | $0.00 | 244.0000 | 50,944,000 | 9999.99% | 0.00% |